114 related articles for article (PubMed ID: 18253960)
21. Evaluation of the platelet count drop method for assessment of platelet function in comparison with "gold standard" light transmission aggregometry.
Lordkipanidzé M; Pharand C; Schampaert E; Palisaitis DA; Diodati JG
Thromb Res; 2009 Sep; 124(4):418-22. PubMed ID: 19250657
[TBL] [Abstract][Full Text] [Related]
22. Major clinical vascular events and aspirin-resistance status as determined by the PFA-100 method among patients with stable coronary artery disease: a prospective study.
Christiaens L; Ragot S; Mergy J; Allal J; Macchi L
Blood Coagul Fibrinolysis; 2008 Apr; 19(3):235-9. PubMed ID: 18388505
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of unresponsiveness to aspirin and/or clopidogrel in patients with stable coronary heart disease.
Lordkipanidzé M; Diodati JG; Schampaert E; Palisaitis DA; Pharand C
Am J Cardiol; 2009 Nov; 104(9):1189-93. PubMed ID: 19840560
[TBL] [Abstract][Full Text] [Related]
24. Monitoring aspirin therapy with the Platelet Function Analyzer-100.
Mortensen J; Poulsen TS; Grove EL; Refsgaard J; Nielsen HL; Pedersen SB; Thygesen SS; Hvas AM; Kristensen SD
Scand J Clin Lab Invest; 2008; 68(8):786-92. PubMed ID: 18651324
[TBL] [Abstract][Full Text] [Related]
25. Aspirin-resistance frequency: a prospective study in 280 healthy Turkish volunteers.
Akay OM; Canturk Z; Akin E; Bal C; Gulbas Z
Clin Appl Thromb Hemost; 2009 Feb; 15(1):98-102. PubMed ID: 18160610
[TBL] [Abstract][Full Text] [Related]
26. Responsiveness to aspirin in patients with unstable angina pectoris by whole blood aggregometry.
Li JB; Dong HM; Jian Z; Wu XJ; Zhao XH; Yu SY; Huang L
Int J Clin Pract; 2009 Mar; 63(3):407-16. PubMed ID: 19222626
[TBL] [Abstract][Full Text] [Related]
27. Relation of platelet aggregation and fibrinogen levels to advancing age in aspirin- and thienopyridine-treated patients.
Koltai K; Feher G; Kenyeres P; Lenart I; Alexy T; Horvath B; Marton Z; Kesmarky G; Toth K
Clin Hemorheol Microcirc; 2008; 40(4):295-302. PubMed ID: 19126992
[TBL] [Abstract][Full Text] [Related]
28. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
[TBL] [Abstract][Full Text] [Related]
29. Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-up.
Linnemann B; Prochnow S; Mani H; Schwonberg J; Lindhoff-Last E
Ann Hematol; 2009 Oct; 88(10):979-88. PubMed ID: 19247655
[TBL] [Abstract][Full Text] [Related]
30. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
Velik-Salchner C; Maier S; Innerhofer P; Kolbitsch C; Streif W; Mittermayr M; Praxmarer M; Fries D
Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196
[TBL] [Abstract][Full Text] [Related]
31. Whole blood multiple electrode aggregometry is a reliable point-of-care test of aspirin-induced platelet dysfunction.
Jámbor C; Weber CF; Gerhardt K; Dietrich W; Spannagl M; Heindl B; Zwissler B
Anesth Analg; 2009 Jul; 109(1):25-31. PubMed ID: 19439684
[TBL] [Abstract][Full Text] [Related]
32. Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry.
Nielsen HL; Kristensen SD; Thygesen SS; Mortensen J; Pedersen SB; Grove EL; Hvas AM
Thromb Res; 2008; 123(2):267-73. PubMed ID: 18499236
[TBL] [Abstract][Full Text] [Related]
33. Cross validation of the Multiple Electrode Aggregometry. A prospective trial in healthy volunteers.
Siller-Matula JM; Gouya G; Wolzt M; Jilma B
Thromb Haemost; 2009 Aug; 102(2):397-403. PubMed ID: 19652892
[TBL] [Abstract][Full Text] [Related]
34. Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function.
Bevilacqua S; Alkodami AA; Volpi E; Cerillo AG; Berti S; Glauber M; Gianetti J
Ann Thorac Surg; 2009 Feb; 87(2):496-502. PubMed ID: 19161767
[TBL] [Abstract][Full Text] [Related]
35. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
Adamopoulos AB; Sakizlis GN; Nasothimiou EG; Anastasopoulou I; Anastasakou E; Kotsi P; Karafoulidou A; Stergiou GS
J Cardiovasc Pharmacol; 2009 Aug; 54(2):163-8. PubMed ID: 19568178
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometric assessment of platelet aspirin resistance using light scattering.
Won DI; Yang DH; Kim DH; Chae SC; Suh JS
Cytometry B Clin Cytom; 2008 Mar; 74(2):110-7. PubMed ID: 18061948
[TBL] [Abstract][Full Text] [Related]
37. Increased platelet volume and aggregation precede the onset of preeclampsia.
Hutt R; Ogunniyi SO; Sullivan MH; Elder MG
Obstet Gynecol; 1994 Jan; 83(1):146-9. PubMed ID: 8272297
[TBL] [Abstract][Full Text] [Related]
38. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
Lepäntalo A; Virtanen KS; Reséndiz JC; Mikkelsson J; Viiri LE; Karhunen PJ; Lassila R
Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433
[TBL] [Abstract][Full Text] [Related]
39. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease.
Kim H; Lee HK; Han K; Jeon HK
Ann Clin Lab Sci; 2009; 39(3):289-94. PubMed ID: 19667414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
